Recent evidence indicates that the nuclear protein CREMα has key functions as both an epigenetic and transcriptional regulator of cytokine expression in T lymphocytes from SLE patients. This review summarizes the most recent findings linking CREMα signaling with T lymphocyte effector functions in healthy individuals and those with SLE and other autoimmune disorders.
